Teva Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 1,813.0 | 2,058.0 | 1,370.0 |
| Net Investing Cash Flow | (1,353.0) | (4,058.0) | (537.8) |
| Net Financing Cash Flow | (362.0) | 2,024.0 | (312.7) |
| Net Change in Cash | 156.0 | 56.0 | 491.5 |
| Depreciation & Amortization | 521.0 | 431.0 | 242.5 |
| Capital Expenditures | (542.0) | (390.0) | (310.1) |
| Cash Dividends Paid | (299.0) | (229.0) | (162.1) |





